Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The RiceX Company was a specialized biotechnology and nutraceutical firm focused on the stabilization and processing of rice bran. The company developed proprietary technology to prevent the rapid enzymatic degradation of rice bran, transforming it into a shelf-stable, nutrient-rich ingredient for the functional food and dietary supplement markets. Its products, such as RiceX Solubles and RiceX Fiber Complex, were marketed for their potential benefits in managing cardiovascular health and blood glucose levels. In 2005, the company merged with NutraCea, which later became RiceBran Technologies, to consolidate their positions in the stabilized rice bran industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RiceX.